Skyrizi
- Product NDC
- 0074-8300
- 11-digit product format
- 000748300
- Labeler code
- 0074
- Product ID
- 0074-8300_9c9f7a2c-c686-4a89-b15d-cfd58ea603d5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- risankizumab-rzaa
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Labeler
- AbbVie Inc.
- Application
- BLA761105
- Marketing category
- BLA
- Marketing start
- 2025-09-03
- Substance
- RISANKIZUMAB
- Active strength
- 180 mg/1.2mL
- Pharmacologic classes
- Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 90ZX3Q3FR7 | RISANKIZUMAB | 1612838-76-2 | RISANKIZUMAB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0074-8300-01 | 00074830001 | 1 SYRINGE in 1 CARTON (0074-8300-01) / 1.2 mL in 1 SYRINGE | 1 syringe | 2025-09-03 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Skyrizi | AbbVie Inc. | 2026-03-19 | HUMAN PRESCRIPTION DRUG LABEL | 173 |